Recent Finacing
Recent Raise
DoubleRainbow Biosciences develops proprietary enzyme-modification and molecular-biosynthesis platforms using genomics, metabolomics, and synthetic biology to produce scalable natural therapeutic and bioceutical candidates targeting oncology, neurological, and metabolic diseases.
